J
Jean François Rossi
Researcher at University of Montpellier
Publications - 49
Citations - 2976
Jean François Rossi is an academic researcher from University of Montpellier. The author has contributed to research in topics: Multiple myeloma & Bone marrow. The author has an hindex of 24, co-authored 49 publications receiving 2596 citations. Previous affiliations of Jean François Rossi include University Hospital Heidelberg & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease
David C. Fajgenbaum,Thomas S. Uldrick,Adam Bagg,Dale Frank,David Wu,Gordan Srkalovic,David Simpson,Amy Y. Liu,David M. Menke,Shanmuganathan Chandrakasan,Mary Jo Lechowicz,Raymond S.M. Wong,Sheila K Pierson,Michele Paessler,Jean François Rossi,Makoto Ide,Jason R. Ruth,Michael P. Croglio,Alexander Suarez,Vera P. Krymskaya,Amy Chadburn,Gisele W. B. Colleoni,Sunita D. Nasta,Raj Jayanthan,Christopher S. Nabel,Corey Casper,Angela Dispenzieri,Alexander Fosså,Dermot Kelleher,Razelle Kurzrock,Peter M. Voorhees,Ahmet Dogan,Kazuyuki Yoshizaki,Frits van Rhee,Eric Oksenhendler,Elaine S. Jaffe,Kojo S.J. Elenitoba-Johnson,Megan S. Lim +37 more
TL;DR: The proposed consensus criteria will facilitate consistent diagnosis, appropriate treatment, and collaborative research and exclude infectious, malignant, and autoimmune disorders that can mimic iMCD.
Journal ArticleDOI
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature
Jérôme Moreaux,Friedrich W. Cremer,Friedrich W. Cremer,Thierry Rème,Thierry Rème,Marc Steffen Raab,Marc Steffen Raab,Karène Mahtouk,Karène Mahtouk,Philine Kaukel,Philine Kaukel,Véronique Pantesco,Véronique Pantesco,John De Vos,John De Vos,Eric Jourdan,Eric Jourdan,Anna Jauch,Anna Jauch,Eric Legouffe,Eric Legouffe,Marion Moos,Marion Moos,Geneviève Fiol,Geneviève Fiol,Hartmut Goldschmidt,Hartmut Goldschmidt,Jean François Rossi,Jean François Rossi,D Hose,D Hose,Bernard Klein,Bernard Klein +32 more
TL;DR: Using gene expression profiling to identify the group of patients who might benefit most from treatment with BAFF/APRIL inhibitors is suggested.
Journal ArticleDOI
Survival and proliferation factors of normal and malignant plasma cells.
Bernard Klein,Karin Tarte,Michel Jourdan,Karene Mathouk,Jérôme Moreaux,Eric Jourdan,Eric Legouffe,John De Vos,Jean François Rossi +8 more
TL;DR: Recent data indicate that these various growth factors may cooperate to provide optimum signaling because they are localized together and with cytoplasmic transduction elements in caveolinlinked membrane caveolae and should provide novel therapeutic targets in multiple myeloma.
Journal ArticleDOI
CD200 is a new prognostic factor in multiple myeloma.
Jérôme Moreaux,Dirk Hose,Thierry Rème,Eric Jourdan,Michael Hundemer,Eric Legouffe,Philippe Moine,Philippe Bourin,Marion Moos,Jill Corre,Thomas Möhler,John De Vos,Jean François Rossi,Hartmut Goldschmidt,Bernard Klein +14 more
TL;DR: Using Affymetrix microarrays, this article identified the expression of the CD200 gene in multiple myeloma cells (MMCs) of 112 patients with newly diagnosed Multiple Myeloma (MM).
Journal ArticleDOI
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma.
Dirk Hose,Thierry Rème,Thomas Hielscher,Jérôme Moreaux,Tobias Messner,Anja Seckinger,Axel Benner,John D. Shaughnessy,Bart Barlogie,Yiming Zhou,Jens Hillengass,Uta Bertsch,Kai Neben,Thomas Möhler,Jean François Rossi,Anna Jauch,Bernard Klein,Hartmut Goldschmidt +17 more
TL;DR: Proliferation assessed by gene expression profiling, being independent of serum-β2-microglobulin, International Staging System stage, t(4;14), and gene expression-based risk scores, is a central prognostic factor in multiple myeloma.